Clinical Trials Browser

Phase 2 × Fluorescein × 1 year × Clear all

NCT06873815 2026-01-12

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

Phase 2 Recruiting

Paget Disease, Extramammary

NCT02691923 2025-08-03

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Phase 2 Recruiting

Brain Neoplasms, Glioma

NCT06054178 2025-07-28

Identification of Nerves Using Fluorescein Sodium

Phase 2 Enrolling by invitation

Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases